FDA Inspection 1014880 — Elite Laboratories Inc.

Elite Laboratories Inc. — FEI 3002644678

The FDA completed an inspection of Elite Laboratories Inc. on April 24, 2017 in Northvale, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Postmarket Surv. and Epidemiology
Location
Northvale, NJ (United States)